TrialBritish journal of haematology2021

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1.

Sara Bringhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.